More importantly, we discover that ARL4C is highly related to TGF‐β1 signalling pathway, which is further confirmed by our discovery that the coexpression of ARL4C and TGF‐β1 predicts worse survival for GC patients than ARL4C or TGF‐β1, respectively. The gene discussed is ARL4C; the disease is gastric cancer.